KYLE ATKINS: Open Payments
NPI 1124496633 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 28 payments from 8 companies in 2025. Trend: 2023 $466 · 2024 $668 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $243 |
| Novo Nordisk Inc | 13 | $233 |
| Lilly USA, LLC | 4 | $73 |
| PFIZER INC. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Exact Sciences Corporation | 1 | $20 |
| Amgen Inc. | 1 | $16 |
Products named: AIRSUPRA, Wegovy, FARXIGA, Ozempic, JARDIANCE, MOUNJARO, Rybelsus, REXULTI.
Industry payments across NC — which companies pay providers there.
